Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Protein engineering of single-chain Fv analogs and fusion proteins.

× No keyword cloud information.

37 in total

Review 1. Generation of recombinant antibodies.

Authors: S M Kipriyanov; M Little
Journal: Mol Biotechnol Date: 1999-09 Impact factor: 2.695

2. Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.

Authors: Barbara E Power; Larissa Doughty; Deborah R Shapira; John E Burns; Ann M Bayly; Joanne M Caine; Zhanqi Liu; Andrew M Scott; Peter J Hudson; Alexander A Kortt
Journal: Protein Sci Date: 2003-04 Impact factor: 6.725

3. Multisite association by recombinant proteins can enhance binding selectivity. Preferential removal of immune complexes from serum by immobilized truncated FB analogues of the B domain from staphylococcal protein A.

Authors: J S Huston; C Cohen; D Maratea; F Fields; M S Tai; N Cabral-Denison; R Juffras; D C Rueger; R J Ridge; H Oppermann
Journal: Biophys J Date: 1992-04 Impact factor: 4.033

Review 4. Biosynthetic antibody binding sites: development of a single-chain Fv model based on antidinitrophenol IgA myeloma MOPC 315.

Authors: J E McCartney; L Lederman; E A Drier; N A Cabral-Denison; G M Wu; R S Batorsky; J S Huston; H Oppermann
Journal: J Protein Chem Date: 1991-12

Protein engineering of single-chain Fv analogs and fusion proteins.

Review 1. Generation of recombinant antibodies.

2. Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.

3. Multisite association by recombinant proteins can enhance binding selectivity. Preferential removal of immune complexes from serum by immobilized truncated FB analogues of the B domain from staphylococcal protein A.

Review 4. Biosynthetic antibody binding sites: development of a single-chain Fv model based on antidinitrophenol IgA myeloma MOPC 315.

5. Single chain dimers of MASH-1 bind DNA with enhanced affinity.

6. Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region.

7. Preparation of biologically active single-chain variable antibody fragments that target the HIV-1 gp120 V3 loop.

8. A fully human scFv phage display library for rapid antibody fragment reformatting.

9. VLR Recognition of TLR5 Expands the Molecular Characterization of Protein Antigen Binding by Non-Ig-based Antibodies.

10. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.